Abnormalities in the TGF-β signalling pathway have been found to lead to a variety of human diseases, such as hypertension, hyperlipidaemia, atherosclerosis and renal fibrosis [7,8,15]. This evidence concerns the gene TGFB1 and atherosclerosis.